Exhibit 99.2 Arcadia Biosciences, Inc. Consolidated Balance Sheets (Unaudited) (In thousands, except share data) | | September 30, | | | December 31, | | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | Assets | | | | | | Current assets: | | | | | | Cash and cash equivalents | $| 1,120 |$ | 4,242 | | Short-term investments | | 4,765 | | — | | Accounts receivable and other receivables, net of allowance for credit losses of | | | | | | $559 and$0 as of September 30, 2025 and December 31, 2024, respect ...